World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02364284
Date of registration: 06/02/2015
Prospective Registration: No
Primary sponsor: Pfizer
Public title: Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP RECOMMEND
Scientific title: Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With Complicated Urinary Tract Infection,Complicated Intra-abdominal Infection and Nosocomial Pneumonia Including Ventilator-associated Pneumonia.
Date of first enrolment: February 2015
Target sample size: 1322
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02364284
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Brazil France Greece Italy Russian Federation Spain
Contacts
Name:     Anne-Laure Fedou
Address: 
Telephone:
Email:
Affiliation:  CHU de Limoges - Hôpital Dupuytren
Key inclusion & exclusion criteria

Inclusion Criteria:

ICF to be obtained (refer slides 26-30) Adult (=18 years) patients Patients with a
diagnosis of at least one of the three conditions hospitalised during the period July 1,
2013 to June 30, 2014 Hospital acquired or healthcare associated cUTI Hospital acquired or
healthcare associated cIAI NP including VAP

Exclusion Criteria:

The patient participated in a clinical trial during the patient selection period
(01-Jul-2013 to 30-Jun-2014) or during the follow-up period* For patients diagnosed with
cUTI: The patient has a diagnosis of hospital acquired or healthcare associated cUTI with
concomitant presence of Fungal UTI with colony count > 10^3/mL



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Intra-abdominal Infection (cIAI) and
Nosocomial Pneumonia (NP)
Urinary Tract Infection (cUTI)
Intervention(s)
Primary Outcome(s)
To describe antibiotic management and document treatment outcome among hospitalized patients with hospital acquired or healthcare associated cUTI, cIAI and NP [Time Frame: 12 months]
Secondary Outcome(s)
To identify potential risk factors related to outcomes of initial antibiotic treatment of hospitalized patients with hospital acquired or healthcare associated cUTI, cIAI and NP [Time Frame: 12 months]
To describe healthcare utilization and costs associated with hospital acquired or healthcare associated cUTI, cIAI and NP initial antibiotic treatment outcome [Time Frame: 12 months]
Secondary ID(s)
D4280R00005
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history